These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189 [TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493 [TBL] [Abstract][Full Text] [Related]
31. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series. Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651 [TBL] [Abstract][Full Text] [Related]
32. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma. De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257 [TBL] [Abstract][Full Text] [Related]
33. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol. Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429 [TBL] [Abstract][Full Text] [Related]
34. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Chen CS; Li FK; Guo CY; Xiao JC; Hu HT; Cheng HT; Zheng L; Zong DW; Ma JL; Jiang L; Li HL Oncotarget; 2016 Feb; 7(6):7241-52. PubMed ID: 26769845 [TBL] [Abstract][Full Text] [Related]
35. Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma. Garin E; Rakotonirina H; Lejeune F; Denizot B; Roux J; Noiret N; Mesbah H; Herry JY; Bourguet P; Lejeune JJ Nucl Med Commun; 2006 Apr; 27(4):363-9. PubMed ID: 16531923 [TBL] [Abstract][Full Text] [Related]
36. 18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer. Risse JH; Pauleit D; Bender H; Rabe C; Fischer HP; Biersack HJ; Bucerius J Cancer Biother Radiopharm; 2009 Aug; 24(4):445-52. PubMed ID: 19694579 [TBL] [Abstract][Full Text] [Related]
37. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report. Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study. Park CH; Suh JH; Yoo HS; Lee JT; Kim DI Clin Nucl Med; 1986 Jul; 11(7):514-7. PubMed ID: 3015472 [TBL] [Abstract][Full Text] [Related]
39. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma? Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125 [No Abstract] [Full Text] [Related]
40. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]